药物对比
Canagliflozin vs Repaglinide
比较Canagliflozin（Invokana）与Repaglinide治疗2型糖尿病。对比机制、获益及副作用。请咨询医生以获得个体化选择。
此页面暂无可用的对比维度。
临床背景
Type 2 diabetes patients selecting an oral agent, especially those with cardiorenal risk versus needs for mealtime insulin secretion.
结论
Canagliflozin is often favored for added organ protection while Repaglinide suits flexible post-meal dosing, depending on the individual patient.
全部药物对比